Safety and operational feasibility of single versus cocktail rabies monoclonal antibodies for post-exposure prophylaxis in a resource-limited setting
PLOS Neglected Tropical Diseases · 23.07.2026 · 20 (7) · e0014274
DOI: 10.1371/journal.pntd.0014274 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 23.07.2026. Verfasst von Nidhi Fotedar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Formerly with the Department of Community Medicine, Kempegowda Institute of Medical Sciences, Hospital & Research Centre, Bengaluru, India. Hauptthemen laut MEDLINE: Post-Exposure Prophylaxis, Rabies, Antibodies, Monoclonal, Rabies Vaccines. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Rabies is almost universally fatal once symptoms develop but is preventable through timely post-exposure prophylaxis (PEP). Global shortages of human and equine rabies immunoglobulin (RIG) have led the World Health Organization to recommend human monoclonal antibodies (mAbs) as acceptable alternatives. Comparative real-world data on single-antibody versus two-antibody cocktail mAbs are limited, particularly from endemic, resource-limited settings.
Methods
A comparative observational study was conducted in a high-volume rabies PEP clinic in India between October 2021 and December 2022. Consecutive patients with category III animal exposures received either a single human anti-rabies mAb (Rabishield; n = 159) or a two-mAb cocktail (Twinrab; n = 159) in combination with WHO-recommended vaccine. Primary outcomes included safety, ease of administration, and operational feasibility. Data were analysed using independent t-tests and chi-square or Fisher’s exact tests, with p < 0.05 considered significant.
Results
Mean age was 29.7 ± 19.4 years in the Rabishield group and 32.8 ± 20.4 years in the Twinrab group. Ease of infiltration was rated “easy” in 66.7% versus 62.9% of patients (p = 0.63). Local adverse events were uncommon, with pain reported in 2.5% versus 7.5% (p = 0.07) and erythema in ≤ 1.3% of participants. No serious systemic adverse events occurred. Rabishield required more vials per patient (2.28 ± 0.84 vs 2.00 ± 0.69; p = 0.001) and had a higher mean infiltration volume (4.7 ± 1.9 mL vs 4.0 ± 1.6 mL; p < 0.001), while wastage was similar between groups (1.03 ± 0.72 mL vs 1.03 ± 0.69 mL; p = 0.95).
Conclusions
Both single and cocktail human anti-rabies mAbs were safe, well tolerated, and operationally feasible in a programmatic setting. The slightly higher volume and vial requirement for Rabishield may have cost and logistics implications. These findings support broader mAb adoption to address RIG shortages in rabies-endemic, resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Formerly with the Department of Community Medicine, Kempegowda Institute of Medical Sciences, Hospital & Research Centre, Bengaluru, India.
- Department of Community Medicine, Kempegowda Institute of Medical Sciences, Hospital & Research Centre, Bengaluru, India.
ORCID-Profile: Nidhi Fotedar
Zitieren
APA
Fotedar, N., & Ravish, H. S. (2026). Safety and operational feasibility of single versus cocktail rabies monoclonal antibodies for post-exposure prophylaxis in a resource-limited setting. PLOS Neglected Tropical Diseases, 20(7), e0014274. https://doi.org/10.1371/journal.pntd.0014274
Vancouver
Fotedar N, Ravish HS. Safety and operational feasibility of single versus cocktail rabies monoclonal antibodies for post-exposure prophylaxis in a resource-limited setting. PLOS Neglected Tropical Diseases. 2026;20(7):e0014274. doi:10.1371/journal.pntd.0014274
BibTeX
@article{Fotedar2026,
author = {Fotedar, Nidhi and Ravish, Haradanahalli Shankariah},
title = {Safety and operational feasibility of single versus cocktail rabies monoclonal antibodies for post-exposure prophylaxis in a resource-limited setting},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {7},
pages = {e0014274},
doi = {10.1371/journal.pntd.0014274}
}
EUVIMED